Literature DB >> 25210812

Synthesis of the zwitterionic repeating unit of the O-antigen from Shigella sonnei and chain elongation at both ends.

Hélène B Pfister1, Laurence A Mulard.   

Abstract

Shigella sonnei O-antigen features a zwitterionic disaccharide repeat encompassing two rare monosaccharides. The synthesis of the AB repeat and of trisaccharides ABA' and B'AB, which validates chain elongation at either end, is reported. All targets were synthesized using a postglycosylation oxidation strategy in combination with imidate chemistry. Precursors to residue A were obtained from L-glucose. The AAT (B) donor and acceptor were obtained from D-glucosamine. A one-step Pd(OH)2/C-mediated deprotection provided the propyl glycoside targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25210812     DOI: 10.1021/ol502395k

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Exploratory N-Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides.

Authors:  Debashis Dhara; Laurence A Mulard
Journal:  Chemistry       Date:  2021-03-01       Impact factor: 5.236

2.  Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1.

Authors:  Benjamin Schumann; Katrin Reppe; Paulina Kaplonek; Annette Wahlbrink; Chakkumkal Anish; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  ACS Cent Sci       Date:  2018-03-14       Impact factor: 14.553

Review 3.  Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates.

Authors:  Archanamayee Behera; Suvarn S Kulkarni
Journal:  Molecules       Date:  2018-08-10       Impact factor: 4.411

Review 4.  Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges.

Authors:  Armelle Phalipon; Laurence A Mulard
Journal:  Vaccines (Basel)       Date:  2022-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.